GSK’s three-in-one inhaler gets positive opinion from EU agency

21

(Reuters) – GlaxoSmithKline said on Friday that a European Medicines Agency (EMA) panel has recommended the company's three-in-one inhaled lung drug.
Source : http://in.reuters.com/